Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Equity Average (2019 - 2025)

Pulmonx (LUNG) has disclosed Equity Average for 7 consecutive years, with $64.6 million as the latest value for Q3 2025.

  • Quarterly Equity Average fell 33.82% to $64.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $64.6 million through Sep 2025, down 33.82% year-over-year, with the annual reading at $102.1 million for FY2024, 25.04% down from the prior year.
  • Equity Average for Q3 2025 was $64.6 million at Pulmonx, down from $73.4 million in the prior quarter.
  • The five-year high for Equity Average was $221.1 million in Q1 2021, with the low at $64.6 million in Q3 2025.
  • Average Equity Average over 5 years is $136.0 million, with a median of $138.9 million recorded in 2023.
  • The sharpest move saw Equity Average surged 215.96% in 2021, then tumbled 33.82% in 2025.
  • Over 5 years, Equity Average stood at $212.5 million in 2021, then fell by 25.3% to $158.7 million in 2022, then decreased by 12.47% to $138.9 million in 2023, then tumbled by 35.32% to $89.9 million in 2024, then dropped by 28.16% to $64.6 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $64.6 million, $73.4 million, and $81.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.